SAR-Aortech Int. PLC-Rplcmt
3i Group PLC
17 October 2000
The following amendment should be made to the 'SAR - Aortech International PLC'
announcement released today at 12:12 under RNS No 6221S.
The disclosure should have been on a SAR 5 form and related to the sale of
75,000 shares and not on a SAR 3 form relating to the acquisition of 75,000
shares as previously published.
All other details remain unchanged.
The full corrected version is shown below.
-------------------------------------------------------------------------------
FORM SAR 5
Date of disclosure 17 OCTOBER 2000
DISCLOSURE UNDER NOTE 3 OF RULE 5 OF THE RULES GOVERNING
SUBSTANTIAL ACQUISITIONS OF SHARES ('SARs')
Date of sale 13.10.00
Sale of AORTECH INTERNATIONAL PLC (name of company)
(1) Class of voting shares Number of shares/rights If rights over shares
(eg ordinary shares) over shares sold sold, as opposed
to the shares
themselves, specify
nature of rights
ORDS 25P 75,000 shares
rights N/A
(2) Resultant total holding Resultant total holding Total percentage
of voting shares (and % of rights over shares
of total voting shares (and % of total voting
in issue) shares in issue)
5,116,678 (16.97%) N/A ( %) 16.97% ( %)
(3) Party making disclosure 3I GROUP PLC
(4) (a) Name of person selling shares or rights over shares 3I GROUP PLC
and, if different, beneficial owner.
(b) Names of any other persons acting by
agreement or understanding 3I BIOSCIENCE INVESTMENT
TRUST PLC
Signed, for and on behalf of the party named in (3) above
(Also print name of signatory) J DAVIES
Telephone and extension number 0207 928 3131
For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers,
Tel. No: 020 7382 9026.
Latest directors dealings
- 9 hours ago Savannah Energy
- 10 hours ago Buccaneer Energy PLC
- 10 hours ago Savannah Energy
- 11 hours ago Carclo
- 11 hours ago Schroder Japan Growth Fund